Breaking News Instant updates and real-time market news.

SNAP

Snap

$12.55

-0.02 (-0.16%)

13:40
08/14/18
08/14
13:40
08/14/18
13:40

Snap Sep 14 calls are among most active single stock options

Snap Sep 14 calls are among most active single stock options. Shares flat at $12.57 and one player bought an 8.1K lot Tuesday morning for 21c per contract. The activity continued into midday and nearly 27K SNAP Sep 14 calls now traded. Open interest is 5.8K and the market is 18 to 19c. Bullish positions opened Tuesday after earnings reported last week - the stock lost 6.8% to $12.23 Wednesday in reaction to the results and has seen a modest 2.8% snapback since that time.

SNAP Snap
$12.55

-0.02 (-0.16%)

08/08/18
LEHM
08/08/18
NO CHANGE
Target $16
LEHM
Overweight
Snap guidance change 'big positive for long-term holders,' says Barclays
Barclays analyst Ross Sandler views Snap's Q2 results as a "mixed bag," with daily active users 2M below his estimate and revenue $20M above his estimate. More importantly, the change in approach towards guidance is "very welcomed and should help to reduce some of the volatility going forward," Sandler tells investors in a post-earnings research note. He believes this is a "big positive for long-term holders looking to get involved." Snap's daily active user growth is still being held back by the redesign and Android headwinds, but these should be done by Q4, Sandler contends. He believes Snap could be in a position to start to improve from here and would initiate positions at current share levels. The analyst has an Overweight rating on Snap with a $16 price target.
08/08/18
DBAB
08/08/18
NO CHANGE
Target $13
DBAB
Hold
Snap reported mixed Q2 results, says Deutsche Bank
Deutsche Bank analyst Lloyd Walmsley views Snap's Q2 results as mixed, with "soft" daily active users but an improving monetization outlook. The analyst is "slightly disappointed" that guidance implies further risk to DAUs in Q3. Further, Snap offered no specific color around the Android re-build in terms of timing or an early look on the impact in test markets, Walmsley tells investors in a post-earnings research note. He keeps a Hold rating on Snap shares with a $13 price target.
08/08/18
MSCO
08/08/18
NO CHANGE
Target $7.5
MSCO
Underweight
Snap monetization limited by fewer users, says Morgan Stanley
Morgan Stanley analyst Brian Nowak keeps an Underweight rating on Snap following the company's Q2 report, noting that its revenue and EBITDA were "better than feared" but stating that its user declines, which are expected to continue in Q3, highlight its challenges and limit its monetization. He now estimates a 3% sequential decline in DAUs to 183M total users in Q3, which is 9% lower than he previously modeled. Nowak maintains his $7.50 price target on Snap shares, which are down about 2% to $12.84 in pre-market trading.
08/08/18
08/08/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. REACTIONS TO TESLA'S TALK OF GOING PRIVATE: Jefferies analyst Philippe Houchois raised his price target for Tesla (TSLA) to $360 from $250 after CEO Elon Musk suggested taking the company private. Going private "feels like the right thing to do," Houchois said. "Distraction or not, the move feels right even if Musk is downplaying how supportive public markets have been," the analyst adds. However, with Tesla unable to take on more debt, Houchois wondered who may fund the potential deal and end up as a new large shareholder. While Morgan Stanley analyst Adam Jonas sympathizes with Elon Musk's argument that Tesla could be better off as a private company, he questioned the feasibility of Musk actually being able to achieve that goal. Taking the company private would assume either that the company is on the verge of generating self-sustaining cash flows or that it can tap into a range of strategic sources of capital not previously at its disposal, said Jonas, who sees strategic value at Tesla but thinks the "LBO math required to support [a price of] $420 is extremely aggressive." MORGAN STANLEY SAYS SOUTHWEST A GOOD FIT FOR BERKSHIRE: Morgan Stanley analyst Kai Pan noted that Berkshire Hathaway (BRK.A) has shifted tone in recent years and become a top three shareholder of the "Big Four" U.S. airlines, including Southwest (LUV). Media reports from Forbes, CNN and others have discussed a possible acquisition by Berkshire of the airline, added Pan. He analyzed a theoretical acquisition and came to the conclusion that Southwest could be a strategic fit for Berkshire and the advantages could also be compelling for the airline. Pan estimates Berkshire could pay a 20-40% premium, or $70-80 per share for Southwest, in such a hypothetical takeover situation. Pan has an Overweight rating and $67 price target on Southwest shares. BARCLAYS POSITIVE ON SNAP GUIDANCE CHANGE: Barclays analyst Ross Sandler views Snap's (SNAP) Q2 results as a "mixed bag," with daily active users 2M below his estimate and revenue $20M above his estimate. More importantly, the change in approach towards guidance is "very welcomed and should help to reduce some of the volatility going forward," Sandler said. He believes this is a "big positive for long-term holders looking to get involved." The analyst kept an Overweight rating on Snap with a $16 price target. WAINWRIGHT SAYS INSMED LIKELY TO BE ACQUIRED: H.C. Wainwright analyst Andrew Fein raised his price target for Insmed (INSM) to $43 from $35 following the 12-2 FDA panel vote in favor of ALIS in refractory nontuberculous mycobacterial patients. Insmed is now likely to be acquired as ALIS "fits well within the pipeline of a number of larger companies," Fein said.

TODAY'S FREE FLY STORIES

PMBC

Pacific Mercantile Bancorp

$9.75

0.025 (0.26%)

16:50
09/20/18
09/20
16:50
09/20/18
16:50
Hot Stocks
Breaking Hot Stocks news story on Pacific Mercantile Bancorp »

EJF Capital reports 7.3%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

MU

Micron

$46.06

1.01 (2.24%)

16:46
09/20/18
09/20
16:46
09/20/18
16:46
Hot Stocks
Breaking Hot Stocks news story on Micron »

Micron up 5.7% to $48.69…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

BHBK

Blue Hills Bancorp

$23.55

0.4 (1.73%)

16:45
09/20/18
09/20
16:45
09/20/18
16:45
Hot Stocks
Breaking Hot Stocks news story on Blue Hills Bancorp »

Blue Hills Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$24.82

0.17 (0.69%)

16:44
09/20/18
09/20
16:44
09/20/18
16:44
Initiation
Teva initiated  »

Teva assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

CRSP

Crispr Therapeutics

$48.90

-3 (-5.78%)

16:44
09/20/18
09/20
16:44
09/20/18
16:44
Initiation
Crispr Therapeutics initiated  »

Crispr Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 21

    Sep

NTLA

Intellia Therapeutics

$31.50

-0.48 (-1.50%)

16:44
09/20/18
09/20
16:44
09/20/18
16:44
Initiation
Intellia Therapeutics initiated  »

Intellia Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

EDIT

Editas Medicine

$32.55

-0.64 (-1.93%)

16:43
09/20/18
09/20
16:43
09/20/18
16:43
Initiation
Editas Medicine initiated  »

Editas Medicine initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMC

Western Asset Mortgage

$11.30

0.055 (0.49%)

16:42
09/20/18
09/20
16:42
09/20/18
16:42
Syndicate
Western Asset Mortgage 6.5M share Spot Secondary; price range $10.85-$11.10 »

Morgan Stanley,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNDA

Vanda Pharmaceuticals

$20.00

0.4 (2.04%)

16:41
09/20/18
09/20
16:41
09/20/18
16:41
Initiation
Vanda Pharmaceuticals initiated  »

Vanda Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

WYNN

Wynn Resorts

$137.32

1.64 (1.21%)

16:41
09/20/18
09/20
16:41
09/20/18
16:41
Hot Stocks
Breaking Hot Stocks news story on Wynn Resorts »

Lone Pine Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDS.A

Royal Dutch Shell

$66.83

0.57 (0.86%)

, RDS.B

Royal Dutch Shell

$68.85

0.56 (0.82%)

16:41
09/20/18
09/20
16:41
09/20/18
16:41
Periodicals
Shell in discussions to sell $1.3B in Gulf Coast assets, Bloomberg says »

Royal Dutch Shell is in…

RDS.A

Royal Dutch Shell

$66.83

0.57 (0.86%)

RDS.B

Royal Dutch Shell

$68.85

0.56 (0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPVG

TriplePoint Venture

$12.97

-0.01 (-0.08%)

16:39
09/20/18
09/20
16:39
09/20/18
16:39
Initiation
TriplePoint Venture initiated  »

TriplePoint Venture…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMPH

KemPharm

$4.70

-0.25 (-5.05%)

16:38
09/20/18
09/20
16:38
09/20/18
16:38
Initiation
KemPharm initiated  »

KemPharm assumed with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLL

Ball Corp.

$44.39

0.15 (0.34%)

16:35
09/20/18
09/20
16:35
09/20/18
16:35
Hot Stocks
Ball Corp. CFO Scott Morrison sells over $1M in company shares »

Ball Corp. CFO Scott…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLIT

Harmonic

$5.20

0.15 (2.97%)

16:34
09/20/18
09/20
16:34
09/20/18
16:34
Initiation
Harmonic initiated  »

Harmonic initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

WMC

Western Asset Mortgage

$11.30

0.055 (0.49%)

16:34
09/20/18
09/20
16:34
09/20/18
16:34
Syndicate
Western Asset Mortgage files to sell 6.5M shares of common stock »

Morgan Stanley, BofA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,944.26

17.99 (0.93%)

, AAPL

Apple

$220.00

1.655 (0.76%)

16:33
09/20/18
09/20
16:33
09/20/18
16:33
Periodicals
Twitch appears to be blocked in China, Abacus reports »

Amazon's (AMZN)…

AMZN

Amazon.com

$1,944.26

17.99 (0.93%)

AAPL

Apple

$220.00

1.655 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

WMC

Western Asset Mortgage

$11.30

0.055 (0.49%)

16:32
09/20/18
09/20
16:32
09/20/18
16:32
Syndicate
Western Asset Mortgage files to sell 6.5M shares of common stock »

Morgan Stanley, BofA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$70.79

0.8 (1.14%)

16:32
09/20/18
09/20
16:32
09/20/18
16:32
Hot Stocks
Merck receives positive CHMP opinion for DELSTRIGO and PILFETRO in E.U. »

Merck announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 23

    Oct

  • 29

    Oct

  • 11

    Jan

  • 16

    Feb

16:30
09/20/18
09/20
16:30
09/20/18
16:30
Options
Preliminary option volume of 24.2M today »

Preliminary option volume…

INDB

Independent Bank

$89.85

0.65 (0.73%)

, BHBK

Blue Hills Bancorp

$23.55

0.4 (1.73%)

16:29
09/20/18
09/20
16:29
09/20/18
16:29
Hot Stocks
Independent Bank to acquire Blue Hills Bancorp »

Independent Bank (INDB),…

INDB

Independent Bank

$89.85

0.65 (0.73%)

BHBK

Blue Hills Bancorp

$23.55

0.4 (1.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRTV

Veritiv

$44.70

-0.65 (-1.43%)

16:29
09/20/18
09/20
16:29
09/20/18
16:29
Syndicate
Veritiv files to sell 1.5M shares of common stock for holders »

Morgan Stanley is acting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRTV

Veritiv

$44.70

-0.65 (-1.43%)

16:29
09/20/18
09/20
16:29
09/20/18
16:29
Syndicate
Veritiv files to sell 1.5M shares of common stock for UWW Holdings, LLC »

Morgan Stanley & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FATE

Fate Therapeutics

$14.02

0.67 (5.02%)

16:26
09/20/18
09/20
16:26
09/20/18
16:26
Syndicate
Fate Therapeutics $100M Spot Secondary; re-offered at $13.50 »

Jefferies, Piper Jaffray…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 21

    Sep

TMDI

Titan Medical

$2.22

0.04 (1.83%)

16:25
09/20/18
09/20
16:25
09/20/18
16:25
Conference/Events
Titan Medical to host business news update and outlook conference call »

Conference call to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 27

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.